- Report
- October 2024
- 194 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- July 2024
- 137 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- March 2025
- 194 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- January 2025
- 150 Pages
Global
From €2367EUR$2,490USD£1,989GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- October 2023
- 190 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- April 2023
- 115 Pages
Global
From €4516EUR$4,750USD£3,794GBP
Pediatric Interventional Cardiology is a specialized field of medicine that focuses on the diagnosis and treatment of congenital and acquired heart diseases in children. It involves the use of minimally invasive techniques such as catheterization, angioplasty, and stenting to treat a variety of conditions, including congenital heart defects, coronary artery disease, and valvular heart disease. Interventional cardiologists also use these techniques to diagnose and treat arrhythmias, heart failure, and other cardiac conditions.
The pediatric interventional cardiology market is growing due to the increasing prevalence of congenital heart defects and other cardiovascular diseases in children. The rising demand for minimally invasive treatments and the development of new technologies are also driving the growth of this market.
Some of the major companies in the pediatric interventional cardiology market include Abbott Laboratories, Boston Scientific Corporation, Medtronic, Edwards Lifesciences Corporation, and St. Jude Medical. Show Less Read more